July 30, 2016 11:00 PM ET

Life Sciences Tools and Services

Company Overview of AltheaDx, Inc.

Company Overview

AltheaDx, Inc. operates as a molecular diagnostics company for pharmacogenetics (PGx) in the United States. The company’s algorithm-based bioinformatic platform and PGx product testing portfolio serve as a tool to assist healthcare providers in identifying optimal drugs for patients, as well as dosing guidelines based on a patient’s genetic make-up, current prescription regimen, and other key factors. Its IDgenetix test enables personalized therapeutic decisions for patients suffering from prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders, and pains. The company also offers research and development services that provide a suite o...

10578 Science Center Drive

Suite 100

San Diego, CA 92121

United States

Founded in 1998

81 Employees

Phone:

858-224-7200

Fax:

858-224-7220

Key Executives for AltheaDx, Inc.

Chief Executive Officer, President and Director
Age: 44
Co-Founder and Chairman of the Board
Age: 57
Senior Vice President Operations
Senior Vice President of Regulatory Affairs & Quality Assurance
Director of Biomarker Development
Compensation as of Fiscal Year 2016.

AltheaDx, Inc. Key Developments

AltheaDx Launches Next-Generation Sequencing Oncology Panel

AltheaDx, Inc. has launched AltheaDx Oncology Panel 150, a CLIA validated next-generation sequencing, or NGS, panel. This panel enables simultaneous testing of 143 solid tumor genes. The AltheaDx Oncology Panel 150 (AOP 150) Assay is a targeted, NGS assay for drug and companion diagnostic development programs. The AOP 150 Assay is based on Thermo Fisher Scientific's Oncomine Comprehensive Assay. It runs on the proven Ion Torrent NGS technology, includes the Ion AmpliSeq library preparation technology, and leverages the Oncomine Knowledgebase, which is one of the collections of oncology data long-trusted by pharmaceutical companies. The AOP 150 Assay is designed to work with minimal sample input per run and is well-suited for analysis of tumor samples extracted from formalin-fixed paraffin-embedded (FFPE) tissue, including small biopsies and fine needle aspirates. With a rapid turnaround time, the AOP 150 assay is capable of detecting thousands of clinically and pharmacologically relevant biomarkers, including single nucleotide somatic variants, insertions and deletions. The AOP 150 Assay is designed to enable pharmaceutical companies the ability to make evidence-based decisions as part of their clinical trial programs.

AltheaDx, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 08:30 AM

AltheaDx, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 08:30 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Greg Hamilton, Chief Executive Officer and Director.

AltheaDx, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015

AltheaDx, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 . Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 1, 2016
--
Private Placement
December 11, 2015
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AltheaDx, Inc., please visit www.altheadx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.